HAL-Inserm est le portail Inserm de l'archive ouverte nationale qui permet le dépôt en ligne des travaux scientifiques et leur consultation.
Contact
Pour répondre au courrier de la Direction Générale, il est de la responsabilité de chaque chercheur Inserm de :
1-Déposer systématiquement les articles publiés à partir de 2020 dans HAL (quelque soit le portail),
2-Adjoindre obligatoirement au dépôt le fichier de l’article (voir l'aide au dépôt dans l'onglet "Informations pratiques").
Derniers dépôts
-
-
Antoine Roquilly, Bruno Francois, Olivier Huet, Yoann Launey, Sigismond Lasocki, et al.. Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial. Intensive Care Medicine, 2023, 49 (5), pp.530-544. ⟨10.1007/s00134-023-07065-0⟩. ⟨hal-04769433⟩
-
Marine Fauny, Nicolas Cohen, Caroline Morizot, Sophie Leclerc-Jacob, Daniel Wendling, et al.. Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases. Inflammatory Intestinal Diseases, 2020, 5 (3), pp.124-131. ⟨10.1159/000507930⟩. ⟨hal-02961341⟩
-
Louison Pineau, Emmanuelle Buhler, Sarah Tarhini, Sylvian Bauer, Valérie Crepel, et al.. Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N‐methyl‐D‐aspartate receptors. Epilepsia, 2024, 65 (7), pp.2111-2126. ⟨10.1111/epi.18000⟩. ⟨hal-04748540⟩
-
Claire Scheffges, Jérôme Devy, Jérôme Giustiniani, Stessy Francois, Lucille Cartier, et al.. Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications. Breast Cancer Research, 2024, 26 (1), pp.28. ⟨10.1186/s13058-024-01785-x⟩. ⟨inserm-04727312⟩
-
-
Benoit Busser, Julien Lupo, Lucie Sancey, Stéphane Mouret, Patrice Faure, et al.. Plasma circulating tumor DNA levels for the monitoring of melanoma patients: landscape of available technologies and clinical applications. BioMed Research International , 2017, Part of Special Issue: Cancer Diagnostic and Predictive Biomarkers 2016, 2017, pp.5986129. ⟨10.1155/2017/5986129⟩. ⟨hal-02059900⟩
-
-
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, Katinka Fischer, Anna Gahlen, et al.. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1100. ⟨10.1212/NXI.0000000000001100⟩. ⟨hal-03538438⟩
-
-
Sophie Leducq, Faaris Zaki, Loes M Hollestein, Christian Apfelbacher, Nikhil Prasanna Ponna, et al.. The majority of observational studies in leading peer-reviewed medicine journals are not registered and do not have a publicly accessible protocol: a scoping review. Journal of Clinical Epidemiology, 2024, 170, pp.111341. ⟨10.1016/j.jclinepi.2024.111341⟩. ⟨hal-04789292⟩
-
-
-
-
Kan-Yao Chen, Shu-Yan Liu, Juan-Juan Tang, Meng-Ke Liu, Xu-Yang Chen, et al.. NLRP3 knockout in mice provided protection against Serratia marcescens-induced acute pneumonia by decreasing PD-L1 and PD-1 expression in macrophages. International Immunopharmacology, 2024, 129, pp.111559. ⟨10.1016/j.intimp.2024.111559⟩. ⟨hal-04789068⟩
-
-
-
Antoine Brault, Isabelle Pontais, Vincent Enouf, Christine Debeuret, Emma Bloch, et al.. Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023–24: a modelling study. The Lancet Child & Adolescent Health, 2024, 8 (10), pp.721-729. ⟨10.1016/S2352-4642(24)00143-3⟩. ⟨pasteur-04501465v2⟩
-
-
